Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesMaximum vs. Mono Androgen Blockade and the Risk of Recurrence in Men With Localized Prostate Cancer Undergoing Brachytherapy
International Journal of Radiation Oncology*Biology*Physics, 09/02/09
Chen RC et al. – There are varied practice patterns in physicians' choice of the extent of concurrent ADT when used with brachytherapy for men with intermediate– or high–risk prostate cancer. Given a lack of demonstrated superiority from either ADT choice, both appear to be reasonable options.
Related Articles
Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target
The Lancet Oncology, 10/01/09
Relevance Score: 48%
Validation of an Arabic ADAM questionnaire for androgen deficiency screening in the Arab community
The Aging Male, 11/13/09
Relevance Score: 45%
Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells
British Journal of Cancer, 10/26/09
Relevance Score: 45%
Is androgen therapy indicated for aging men?
Sexuality, Reproduction & Menopause, 10/05/09
Relevance Score: 45%
Complete androgen insensitivity syndrome: diagnosis and management
Expert Review of Endocrinology & Metabolism, 11/17/09
Relevance Score: 44%
Today in Radiotherapy (XRT)...keeping you current
Receive free subspecialty "5-minute updates" via email
Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review
Pediatric Radiology, 12/15/09
Underutilization of radiotherapy for lung cancer in New South Wales, Australia
Cancer, 12/15/09
Emerging applications of stereotactic radiotherapy in head and neck cancer
Neurosurgical Focus, 12/15/09
Sponsor
Article Search
Sponsor